jueves, 4 de octubre de 2018

TUTI-16 | Clinical Trials, Side Effects | AIDSinfo

TUTI-16 | Clinical Trials, Side Effects | AIDSinfo

AIDSinfo logo Image



TUTI-16

 Other Names: Thymon Universal Tat ImmunogenDrug Class: Therapeutic VaccinesOrganization: Thymon, LLCPhase of Development: TUTI-16 is in Phase I/II development as a therapeutic HIV vaccine.

(Compound details obtained from Treatment Action Group website1 and ClinicalTrials.gov2)

No hay comentarios:

Publicar un comentario